Erin is leading a new medical weight loss program at New Beauty & Wellness to assist clients on their weight loss journey and to the improvement of overall health and well-being
Introduction to Zepbound Dry Eye Syndrome Zepbound Dry Eye Syndrome: Multiple case reports have documented instances of dry eye syndrome among users of GLP-1 receptor agonists
excels in high-volume order support
Precautions: Notify your veterinarian if your dog: Is lactating or pregnant Has high blood pressure Suffers from heart disease Has a bleeding disorder Is retaining fluid Suffers from congestive heart failure Has been diagnosed with kidney or liver disease Has bleeding or an ulcer in the stomach Is allergic to any NSAID, including aspirin FAQ Tell your veterinarian if your pet has an allergy to aspirin or any other NSAID, an ulcer or bleeding in the stomach, liver or kidney disease, congestive heart failure, fluid retention, bleeding disorders, heart disease or high blood pressure
We identified cases of diabetes at subsequent visits using information on glucose-lowering medication use (self-report or medication inventory), biochemical measures of hyperglycaemia (FG 7.0 mmol/l or non-FG 11.1 mmol/l, HbA 1c 48 mmol/mol [6.5%] at visits 5, 6, 7, or OGTT 2 h glucose 7.8 mmol/l at visit 4
Beyond weight outcomes, the Phase 2 obesity trial also reported improvements in several cardiometabolic markers, including: Reductions in waist circumference Improvements in fasting glucose and insulin sensitivity Favourable changes in blood pressure and lipid profiles Phase 3 trials understood to form part of the TRIUMPH programme are now underway, evaluating retatrutide in broader populations including people with type 2 diabetes and cardiovascular disease
